Evaluating Emerging ADC Designs to Understand Their Impact on Safety Profiles – Where Are We Headed?
Time: 11:00 am
day: Scientific Program Day Two
Details:
- Reviewing new ADC designs and how they may lead to improved safety profiles such as reduced neutropenia and GI toxicities
- Discussing the challenges of preclinical to clinical translation of safety profiles – how can we design ADCs to be safer based on preclinical evaluation?
- Exploring how ADC design innovations will support future differentiation and improve clinical benefit in the future
